Results 141 to 150 of about 13,363 (168)
[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]
Zhuang H.
europepmc +1 more source
[<i>Hugan</i> Decoction alleviates non-alcoholic fatty liver disease in rats by activating the AMPK/m-TOR signaling pathway and reducing lipid synthesis]. [PDF]
Shang D, Li W, Cui L, Chen M.
europepmc +1 more source
[Clinical progress in stem cell therapy for end-stage liver disease]. [PDF]
Pan YF, Xie YB, Shi L, Shi M, Wang FS.
europepmc +1 more source
ホウシャセイ シキソ (131I Rose Bengal)二 ヨル カン ビョウタイ セイリ ノ カイセキ 二 カンスル ケンキュウ [PDF]
Matsumoto, Akira +2 more
core
[<i>Ching Shum</i> Pills alleviates non-alcoholic fatty liver disease in mice by ameliorating lipid metabolism disorders]. [PDF]
Luo B +7 more
europepmc +1 more source
[Analysis and comparison of bile acid metabolism characteristics in children and adults with metabolic- associated fatty liver disease]. [PDF]
Yang CH +7 more
europepmc +1 more source

